Solventum Corp filed an 8-K on August 13, 2025, disclosing a reduced cash consideration for the acquisition of its purification and filtration business by Thermo Fisher Scientific from $4.10 billion to $4.00 billion. This follows the exclusion of Solventum's drinking water filtration business from the transaction details reported earlier on February 25, 2025.